The AACR Rare Cancers Initiative: Uniting Researchers, Undoing Barriers, and Unleashing Progress

Steve Schneible / aacr - At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President Lillian L. Siu, MD, FAACR, announced the AACR Rare Cancers Initiative. Learn more about how this new Initiative will marshal global…

AI Summary: The AACR has unveiled a Rare Cancers Initiative to coordinate researchers, streamline data sharing, and speed therapeutic development for uncommon tumor types. By pooling expertise, funding and networks, the program seeks to overcome the chronic scarcity of trials and resources that leave rare‑cancer patients waiting for attention that’s been hard to come by.

#healthcare #biotech #drugdevelopment #oncology #cancerresearch #researchfunding #clinicaltrials #healthdisparities

4 days / oncodaily


Back to Top / Sat, July 25, 2026, 7:21 pm / permalink 27683 / 2 stories in 5 hrs /




Related Stories


ELCC 2026 showcases lung-cancer trials, new data, and collaborations / 3 months

Agenus halts BATTMAN trial, launches ROBBIN replacement / 1 hr

AstraZeneca deal to bring sunvozertinib to US expands access for EGFR Exon20 patients / 7 days

Phase I lung cancer trials consolidating at top-performing U.S. sites / 3 months

Nine‑year CheckMate‑214 follow‑up confirms durable immunotherapy benefit / 21 days

Teclistamab shows survival benefit prompting earlier use discussions / 5 wks

Introducing ISCO 2026 chairs and program highlights / 3 months

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Medicaid, Reproductive Health, Supplements, Cancer Screening and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.